CLINICAL_TRIALS
trial_result
· 2020-02-17
Clinical Trial Update: PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis [Phase 1]
Summary
Phase 1 trial comparing SAIT101 with MabThera/Rituxan in rheumatoid arthritis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Archigen Biotech Limited | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2020-02-17